{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01949",
      "entity_text" : "SSRI",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:439260",
      "entity_text" : "noradrenaline",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In clinical studies, the Sequenced Treatment Alternatives to Relieve Depression (STAR * D) trial demonstrated that bupropion, a dopamine and noradrenaline reuptake inhibitor, augments antidepressant action of SSRI in patients with incomplete response to initial SSRI treatment [XREF_BIBR, XREF_BIBR], supporting the role of D1 receptors for the enhancement of antidepressant action.",
  "reading_complete" : "2020-08-08T13:55:35Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:49:29Z",
  "trigger" : "augments",
  "evidence" : [ "noradrenaline reuptake inhibitor, augments antidepressant action of SSRI" ],
  "pmc_id" : "7244404",
  "score" : 0
}